Recent Posts
Regulatory Changes Are Shaping the Cost of GLP-1 Medications In December 2024, the U.S. Food and Drug Administration (FDA) announced the resolution of the tirzepatide shortage. Which is the active ingredient in Eli Lilly’s Mounjaro and Zepbound. During the shortage, compounding pharmacies were allowed to produce versions of tirzepatide to help meet demand. However, now that the shortage is resolved, the FDA is requiring ...
The Growing Problem of Medical Waste and Sharps Disposal Every year, millions of used needles and syringes are discarded, which can create significant environmental and public health risks. Individuals who self-inject medications, such as those managing diabetes, hormone therapy, or weight-loss treatments, often lack clear and sustainable options for disposing of their sharps. Traditional disposal methods, including placing ...
Every day, healthcare facilities, pharmacies, and homes generate medical waste. Items like used needles, syringes, and other sharps or medical waste. While these materials are essential for treating illnesses and managing health, their improper disposal poses significant risks to people and the environment. This issue is more than just a healthcare problem; it’s a community-wide concern that affects us all. Why Improper ...
